Skip to main content
. Author manuscript; available in PMC: 2017 Apr 26.
Published in final edited form as: Neurourol Urodyn. 2016 Jul 26;36(4):1151–1154. doi: 10.1002/nau.23079

Table I.

Patient Demographics.

Patient Demographics
Patient Variable Mean (SD)

Age 61.9 (15.8)

BMI 28.2 (6.6)

AUA-SS 21.4 (7.4)

n (%)

Diabetes mellitus 49 (24.5)

Bowel dysfunction: 86 (43.0)
        Constipation 37 (43.0)
        IBS 35 (40.7)
        Other 14 (16.3)

Cardiovascular disease: 53 (26.5)
        CAD/PVD/MI 32 (60.4)
        Arrhythmias 6 (11.3)
        Structural/valve disease 7 (13.2)
        CVA 8 (15.1)

Tobacco use 35 (17.5)

Hyperlipidemia 91 (45.5)

Hypertension 110 (55.0)

Peripheral vascular disease 21 (10.5)

Post-menopausal 141 (70.5)

Neurologic disease: 105 (52.6)
        Multiple sclerosis 23 (21.9)
        Spinal cord injury 11 (10.5)
        Parkinson's disease 2 (1.9)
        CVA with neurologic sequelae 17 (16.2)
        Spinal surgery 32 (30.5)
        Other 20 (19.0)

Peripheral neuropathy 45 (22.5)

Pelvic radiation 6 (3.0)

Recurrent UTI 94 (47.0)

History of AUR 83 (41.5)

Presenting Symptomatology*:
        OAB (urgency, frequency, UUI) − (29.0)
        AUR − (32.5)
        Recurrent UTI − (31.5)
        Incomplete emptying, hesitancy − (7.0)

POP
    Grade: 8 (25.0)
        1 11 (34.4)
        2 12 (37.5)
        3 12 (37.5)
        4 1 (3.1)
    Compartment:
        Anterior/Anterior +Apical 26 (81.3)
        Isolated Apical 3 (9.4)
        Isolated Posterior 3 (9.4)

UDS DO 28 (14.0)

UDS compliance abnormality 15 (7.5)
*

Only % shown as patients may have initially presented with more than 1 symptom